Sonoma Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1999-01-01
- Employees
- 171
- Market Cap
- $4.4M
- Website
- http://www.sonomapharma.com
- Introduction
Sonoma Pharmaceuticals, Inc. engages in the development and production of hypochlorous acid (HOCl) products for wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Boulder, CO.
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
2
FDA:2
Drug Approvals
Clinical Trials
No trials found
News
Sonoma Pharmaceuticals' Hypochlorous Acid-Based Acne Products Gain UK Regulatory Approval
Sonoma Pharmaceuticals has secured MHRA registration for its hypochlorous acid-based acne products, which will be distributed through 1,200+ stores of a leading UK pharmacy chain.
Sonoma Pharmaceuticals Gains FDA Clearance for Enhanced Microcyn Hydrogel
Sonoma Pharmaceuticals has received FDA 510(k) clearance for its Microcyn-based hydrogel, enhancing its wound care applications.